Research / A / Fundamental state Inspectable configuration
State dimensions Filing 0001090872-18-000009 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
148.51% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.98% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
25.12% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
9.44% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
49.25% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
53.40% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
17.83% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
7.55% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.99% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 40 states Self-history eligible
Oct 31, 2021 8/8 normalized Level 3 Jan 31, 2022 9/9 normalized Level 3 Apr 30, 2022 9/9 normalized Level 3 Jul 31, 2022 9/9 normalized Level 3 Oct 31, 2022 9/9 normalized Level 3 Jan 31, 2023 9/9 normalized Level 3 Apr 30, 2023 9/9 normalized Level 3 Jul 31, 2023 9/9 normalized Level 3 Oct 31, 2023 9/9 normalized Level 3 Jan 31, 2024 9/9 normalized Level 3 Apr 30, 2024 9/9 normalized Level 3 Jul 31, 2024 9/9 normalized Level 3 Oct 31, 2024 9/9 normalized Level 3 Jan 31, 2025 9/9 normalized Level 3 Apr 30, 2025 9/9 normalized Level 3 Jul 31, 2025 9/9 normalized Level 3 Oct 31, 2025 9/9 normalized Level 3 Jan 31, 2026 9/9 normalized Level 3 Apr 30, 2026 9/9 normalized Level 3 Jul 31, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 147.81%
Current 148.51%
Delta 0.70% Capex Intensity Decreased
Previous 4.95%
Current 3.98%
Delta -0.97% Cash Generation Increased
Previous 17.75%
Current 25.12%
Delta 7.37% Growth Decreased
Previous 13.50%
Current 9.44%
Delta -4.06% Inventory Pressure Decreased
Previous 50.21%
Current 49.25%
Delta -0.95% Margin Decreased
Previous 55.57%
Current 53.40%
Delta -2.17% Profitability Decreased
Previous 19.74%
Current 17.83%
Delta -1.91% R And D Intensity Decreased
Previous 7.68%
Current 7.55%
Delta -0.13% Sbc Intensity Decreased
Previous 2.56%
Current 0.99%
Delta -1.56% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.